11 Mar 2014

BioLineRx to Report Fourth Quarter and Year End 2013 Results on March 17, 2014

Customize font size:
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it will release its financial results for the quarter and year ended December 31, 2013 on Monday, March 17, 2014, before the U.S. markets open. 
The Company will host a conference call on Monday, March 17 at 10:00 a.m. EDT featuring remarks by Kinneret Savitsky, Ph.D., CEO of BioLineRx, and Philip Serlin, Chief Financial and Operating Officer of BioLineRx. A presentation will be provided on BioLineRx’s website, to accompany management’s remarks on the conference call. The conference call will be available via webcast and can be accessed through the Investor Relations section of BioLineRx’s website, www.biolinerx.com. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast. To dial into the conference call, please dial 1-888-668-9141 from the U.S. or +972-3-918-0609 internationally.   
A replay of the conference call will be available approximately two hours after completion of the live conference call at www.biolinerx.com. A dial-in replay of the call will be available until March 20, 2014; please dial 1-888-269-0005 from the U.S. or +972-3-925-5938 internationally.